ACT-903

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameACT-903
Drug Alias NameACT903
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis stimulantsTubulin polymerisation inhibitorsMitosis inhibitors +[4] 
TargetsTubulin
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Cancer TechnologiesAbzena PLC
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Cancer TechnologiesAbzena PLC
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A